Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Effects of Kinesio Taping Techniques in COPD Patients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04241510
Recruitment Status : Not yet recruiting
First Posted : January 27, 2020
Last Update Posted : January 28, 2020
Sponsor:
Information provided by (Responsible Party):
Burcu Camcıoğlu Yılmaz, Muğla Sıtkı Koçman University

Brief Summary:
Study will investigate effects of two different kinesio taping techniques on pulmonary parameters of patients with COPD.

Condition or disease Intervention/treatment Phase
Chronic Obstructive Pulmonary Disease Device: Kinesio Taping Not Applicable

Detailed Description:
Chronic Obstructive Pulmonary Disease (COPD) is an irreversible, progressive, treatable airway disease which causes dyspnea, wheezing, coughing and increased secretions in airways. Thoracic and respiratory mechanics are impaired, respiratory muscle strength and functional exercise capacity is decreased in patients with COPD. As a result dyspnea, limitation in activities of daily living, postural impairments, muscle length-strength relationship changes and increased mechanical loads on respiratory muscles occur. In literature it has been demonstrated that Kinesio Taping have therapeutic effects on respiratory functions and functional exercise capacity in patients with chronic neurological diseases who has additional respiratory impairments. Although there are several studies in literature investigating the effects of facilitation and inhibition taping techniques applied on respiratory muscles in patients with COPD, effects of thoracic and postural mechanical correction techniques as an alternative treatment modality in patients with COPD have not been investigated yet. In present study, effects of thoracic mechanical correction and facilitation taping techniques in patients with COPD will be investigated, and data will be collected for effects of thoracic mechanical correction taping on pulmonary parameters in patients with COPD.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 30 participants
Allocation: Randomized
Intervention Model: Crossover Assignment
Intervention Model Description: Prospective, Double-Blinded, Randomized Crossover Study
Masking: Double (Participant, Outcomes Assessor)
Masking Description: Evaluation of patients after taping application will be done by another physiotherapist who does not know the taping techniques and also cannot see the taped area by clothes of patients.
Primary Purpose: Treatment
Official Title: Effects of Kinesio Taping Techniques on Pulmonary Parameters and Functional Exercise Capacity in Patients With Chronic Obstructive Pulmonary Disease
Estimated Study Start Date : February 1, 2020
Estimated Primary Completion Date : May 1, 2020
Estimated Study Completion Date : August 1, 2020

Resource links provided by the National Library of Medicine

MedlinePlus related topics: COPD

Arm Intervention/treatment
Active Comparator: Facilitation Tape
Diaphragm and Intercostal muscles will be taped with facilitation technique. After 30 minutes of application patients will be evaulated for pulmonary parameters, functional exercise capacity and dyspnea.
Device: Kinesio Taping
Kinesio Taping is a special taping method developed by Dr. Kenzo Kase in 1973. This technique triggers natural healing responses of human body by activating nervous and circulatory systems. The tapes are thin, latex-free, cotton, porous and anti-allergenic, with equal thickness of epidermis. It has elastic properites which allows the tape to elongate to %55-60 of its original lenght. Tape can be used up to 1 week even after sweating or cleaning with water. There are different application techniques for different purposes. Facilitation technique facilitates muscle contractions and supports muscle function. Mechancial correction technique is used for joint positioning and correcting motion of muscle-joint dynamics.

Active Comparator: Mechanical Correction Tape
Thorax will be taped with mechanical correction technique. After 30 minutes of application patients will be evaulated for pulmonary parameters, functional exercise capacity and dyspnea.
Device: Kinesio Taping
Kinesio Taping is a special taping method developed by Dr. Kenzo Kase in 1973. This technique triggers natural healing responses of human body by activating nervous and circulatory systems. The tapes are thin, latex-free, cotton, porous and anti-allergenic, with equal thickness of epidermis. It has elastic properites which allows the tape to elongate to %55-60 of its original lenght. Tape can be used up to 1 week even after sweating or cleaning with water. There are different application techniques for different purposes. Facilitation technique facilitates muscle contractions and supports muscle function. Mechancial correction technique is used for joint positioning and correcting motion of muscle-joint dynamics.

No Intervention: No Tape
Patients will be evaulated for pulmonary parameters, functional exercise capacity and dyspnea with no tape.



Primary Outcome Measures :
  1. Pulmonary Function Test [ Time Frame: 30 minutes after every application ]
    Pulmonary functions will be evaulated in laboratory conditions. Dynamic lung volumes will be measured using standardized spirometric measurement regulations established by ATS/ERS guidelines.

  2. Respiratory Muscle Strength [ Time Frame: 30 minutes after every application ]
    Respiratory muscle strenght will be measured as Maximum Inspiratory Pressure & Maximum Expiratory Pressure with MicroMPM device. Measuring procedure will be held according to ERS guidelines. Measurements will be interpreted with Black and Hyatt's references.

  3. Functional Exercise Capacity [ Time Frame: 30 minutes after every application ]
    Functional exercise capacity will be measured with 6-minute walk test. Cardiovascular paremeters, dyspnea, respiratory rate and fatigue will be evaulated before, during and after the test .

  4. Dyspnea [ Time Frame: 30 minutes after each application ]
    Dyspnea in daily living was evaluated by the Modified Medical Research Council Dyspnea Scale. The scale consists in five statements that describe almost the entire range of dyspnea from none (Grade 0) to almost complete incapacity (Grade 4). Higher scores indicates increased dyspnea perception.


Secondary Outcome Measures :
  1. Perception of Disease [ Time Frame: 30 minutes after each application. ]
    COPD Assesment Test (CAT) will be used to evaulate patients perception of symptoms.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   40 Years to 80 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Male and female COPD patients aged between 40-80 years
  • Diagnosed with COPD stage I-II-III-IV according to GOLD 2019 criterias
  • Able to speak, understand and read Turkish language
  • Volunteering to participate in study

Exclusion Criteria:

  • Unstable or acutely exacerbated patients with COPD
  • Alterations in medical treatment in last 6 months
  • Having comorbidities that affect directly cardiopulmonary system, uncontrolled arterial hypertension, severe congestive heart failure, coronary arterial disease, heart valve disease
  • Orthopaedic, neurological, psychiatric disease, peripheral/central nervous system diseases, mental retardation, antidepressants usage, metabolic impairments, malignancy
  • Unable to cooperate for measurement and treatment techniques used in study
  • Irritation, infection, allergic reaction, scarred burn or open wound around application area
  • Enrolled in a comprehensive pulmonary rehabilitation program before study
  • Application of Kinesio Tape to any body region in the past
  • History of an open heart surgery or other thoracic surgeries

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04241510


Contacts
Layout table for location contacts
Contact: Burcu Camcıoğlu Yılmaz, PT, PhD 5399442501 ext +90 burcu.camcioglu@yahoo.com
Contact: Metehan Sarıkaya, MSc. Student 5435804304 ext +90 metehansarikaya304@gmail.com

Locations
Layout table for location information
Turkey
Muğla Sıtkı Koçman University Training and Research Hospital
Muğla, Menteşe, Turkey, 48000
Contact: Burcu Camcıoğlu Yılmaz, Ph.D    5399442501 ext +90    burcu.camcioglu@yahoo.com   
Principal Investigator: Metehan Sarıkaya, MSc. Student         
Principal Investigator: Burcu Camcıoğlu Yılmaz, PT, PhD         
Sub-Investigator: Damla M Boyacı, MSc. Student         
Sub-Investigator: Özge Oral Tapan, Dr         
Sub-Investigator: Utku Tapan, Dr         
Sponsors and Collaborators
Muğla Sıtkı Koçman University
Investigators
Layout table for investigator information
Study Director: Burcu Camcıoğlu Yılmaz, PT, PhD Muğla Sıtkı Koçman University
Principal Investigator: Metehan Sarıkaya, MSc. Student Muğla Sıtkı Koçman University
Publications of Results:
Kinesio Tape® Applied to the Thorax Augments Ventilatory Efficiency during Heavy Exercise. Int J Exerc Sci. 2013;6(2):8.
Aydoğan Arslan S, Daşkapan AD, Özünlü Pekyavaş N, Sakızlı E. Effects of Kinesio Taping Applied to Diaphragm Muscle on Aerobic Exercise Capacity and Pulmonary Function in Sedentary Individuals. Anadolu Klin Tıp Bilim Derg. 2018;23(2):68-72.
Zübeyir S, Nilüfer K, Burcu C, Onur A, Bahar K, Ufuk YS, et al. The Effect of Kinesiology Taping on Respiratory Muscle Strength. J Phys Ther Sci. 2012;24(3):241-4.
Bostancı N., Yiğit Z., Baltacı G., Gürses H. Effects of kinesio taping method on pulmonary function, respiratory muscle strength and functional capacity in patients with chronic heart failure. Am J Respir Crit Care Med. 2018;197.

Other Publications:
Kenso Kase, Jim Wallis, Tsuyoshi Kase - Clinical Therapeutic Application Kinesio® Taping Manual. 2nd ed. Kinesio; 2003. 12-39 p.
Kase K. Kenzo Kase. - Illustrated Kinesio Taping. In: 4th ed. p. 6-12, 72-5.
Gibson GJ, Whitelaw W, Siafakas N, Supinski GS, Fitting JW, Bellemare F, et al. ATS/ERS Statement on respiratory muscle testing. Am J Respir Crit Care Med. 2002;166(4):518-624.

Layout table for additonal information
Responsible Party: Burcu Camcıoğlu Yılmaz, PT, PhD, Muğla Sıtkı Koçman University
ClinicalTrials.gov Identifier: NCT04241510    
Other Study ID Numbers: KPR1
First Posted: January 27, 2020    Key Record Dates
Last Update Posted: January 28, 2020
Last Verified: January 2020
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by Burcu Camcıoğlu Yılmaz, Muğla Sıtkı Koçman University:
Chronic Obstructive Pulmonary Disease
Mechanical Correction
Facilitation
Thoracic Taping
Kinesio Taping
Respiratory Muscle Strength
Pulmonary Functions
Functional Exercise Capacity
Additional relevant MeSH terms:
Layout table for MeSH terms
Lung Diseases
Lung Diseases, Obstructive
Pulmonary Disease, Chronic Obstructive
Respiratory Tract Diseases